Articles
-
Will Robots Replace Doctors?
Senior Fellow Bob Kocher paired with Zeke Emanuel examine why artificial intelligence may lead to more evidence-based care, more personalized care, and fewer errors, it has the potential to unintentionally exacerbate many of the worst aspects of our current healthcare system.
Categorized in -
Joint Recommendations of USC-Brookings Schaeffer Initiative for Health Policy and AEI Scholars to Reduce Healthcare Costs
The experts recommendations to the Senate committee aimed at four main goals: improving incentives in private insurance, removing state regulatory barriers to provider market competition, improving incentives in the Medicare program, and promoting competition in the pharmaceutical market.
Categorized in -
Schaeffer Center Celebrates Ten Years of Impact
Ten years ago, Leonard Schaeffer shared his vision with USC leadership: he envisioned an academic center that was grounded in the rigorous, evidence-based research of a university, but would move beyond the university to inform health policy.
-
A New Way to Pay for Innovative Drugs, Provide Universal Access and Not Break the Bank
Neeraj Sood penned an analysis of Louisiana’s new path to curing hepatitis C among its Medicaid and prison populations. It is the first state to implement a solution proposed by Sood in a National Academies of Sciences consensus report and in a leading medical journal.
Categorized in -
Federal Policy to End Surprise Billing: Building on Prior Approaches
USC-Brookings Schaeffer Initiative experts review differences among two proposals to combat surprise medical bills in the 115th Congress and outline some key considerations for the next wave of federal surprise billing policy.
Categorized in -
Ending Drug Rebates will Increase Medicare Part D Premiums, but Most Seniors will be Insulated From It
Erin Trish and Dana Goldman argue eliminating drug rebates will increase the cost of Medicare Part D premiums, but most seniors will be not feel the effects. They say seniors should ignore pharmacy benefit managers’ alarm raised by the proposal.
Categorized in -
American Drug Overdose Death Rates the Highest Among Wealthy Nations
Drug overdose mortality has reached unprecedented levels in the U.S., more than tripling over the past 20 years. Is this a uniquely American epidemic or are other high-income counties facing a similar crisis? RCMAR Scientist and USC Leonard Davis School Assistant Professor Jessica Ho looks at the data.
-
Even if it Survives the Courts, ObamaCare Needs Help
In an op-ed for The Hill, Schaeffer Center professor John Romley and Cedars-Sinai president and CEO Thomas Priselac write that step one to fix the ACA is accepting that payment cuts and cost shaming do not work.
Categorized in -
Reducing Unfair Out-of-Network Billing — Integrated Approaches to Protecting Patients
It may be possible to balance the competing goals of consumer protection and market innovation in state and federal oversight of health plan networks, according to a new opinion piece in The New England Journal of Medicine.
Categorized in -
The U.S. Should Assess the Economic Value of Drugs Rather Than Leave it up to Other Countries
Why are prescription drugs are often priced lower overseas? Many countries perform detailed assessments of the economic value of drugs and their benefits, and this could work in the U.S., says William Padula
Categorized in